EXPERT-C: A randomized, phase II European multicenter trial of neoadjuvant capecitabine plus oxaliplatin chemotherapy (CAPOX) and chemoradiation (CRT) with or without cetuximab followed by total mesorectal excision (TME) in patients with MRI-defined, high-risk rectal cancer.

Abstract

3513 Background: This trial evaluates the addition of C to our previously described treatment strategy of neoadjuvant chemotherapy before CRT and TME in patients with MRI selected high-risk operabl...